Based on the previous reports, the miR-29 family is downregulated in AD patients, causing a higher level of expression for their target, BACE1 (Hébert et al., 2008; Shioya et al., 2010; Zong et al., 2011). This evidence concerns the gene BACE1 and Alzheimer disease.